What Researchers Did
Researchers investigated osseointegrated implant failure rates in 78 cancer patients across three groups: irradiated, non-irradiated, and irradiated with adjunctive hyperbaric oxygen therapy.
What They Found
Implant failure was significantly higher in irradiated patients (53.7%) compared to non-irradiated patients (13.5%) and irradiated patients treated with hyperbaric oxygen (8.1%). Additionally, hyperbaric oxygen therapy significantly improved implant survival in a case-control group, reducing losses from 34 of 43 implants to 5 of 42 implants.
What This Means for Canadian Patients
For Canadian cancer patients requiring dental implants in irradiated areas, adjunctive hyperbaric oxygen therapy could significantly improve implant success rates. This approach may reduce the need for repeat procedures and improve long-term oral rehabilitation outcomes.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada nor involved Canadian researchers or participants.
Study Limitations
A limitation of this study is its case-controlled design, which may be subject to selection bias compared to a randomized controlled trial.